The total return over the past 12 months is -98.99% vs. +16.94% for the S&P 500. So far it's up -98.11% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (98.98%) | (96.28%) | (92.59%) | (77.22%) | N/A | N/A |
| Total Return CAGR | (98.99%) | (96.29%) | (92.60%) | (77.25%) | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
GlucoTrack, Inc. (GCTK)
| Year | Start price | End price | GCTK Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $58.05 | $1.11 | (98.11%) | +14.51% | (112.62%) |
| 2025 | $6,714.00 | $58.05 | (99.14%) | +17.72% | (116.86%) |
| 2024 | $23,535.00 | $6,714.00 | (71.47%) | +24.89% | (96.36%) |
| 2023 | $126,899.85 | $23,535.00 | (81.45%) | +26.19% | (107.64%) |
| 2022 | $375,299.40 | $126,899.85 | (66.19%) | (18.17%) | (48.02%) |
| 2021 | $415,349.25 | $375,299.40 | (9.64%) | +28.74% | (38.38%) |
| 2020 | $702,000.00 | $415,349.25 | (40.83%) | +18.37% | (59.20%) |
| 2019 | $585,000.00 | $702,000.00 | +20.00% | +31.22% | (11.22%) |
| 2018 | $2,339,996.10 | $585,000.00 | (75.00%) | (4.56%) | (70.44%) |
| 2017 | $2,925,000.00 | $2,339,996.10 | (20.00%) | +21.70% | (41.70%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
